Literature DB >> 17072648

Expression of ets-1 is not affected by N-ras or H-ras during oral oncogenesis.

Eleftherios Vairaktaris1, Georgios Papageorgiou, Spyridoula Derka, Panagiota Moulavassili, Emeka Nkenke, Peter Kessler, Stavros Vassiliou, Veronica Papakosta, Sofia Spyridonidou, Antonis Vylliotis, Andreas C Lazaris, Sofia Anagnostopoulou, Constantinos Mourouzis, Christos Yapijakis, Efstratios Patsouris.   

Abstract

PURPOSE: To determine whether ras-activated cascades lead to activation of ets-1 expression in sequential histological stages of oral oncogenesis in an experimental animal model.
METHODS: Thirty-seven Syrian golden hamsters were divided into three experimental groups (A, B, C) and one control group. The hamsters' buccal pouches in experimental groups were treated with 0.5% 9, 10-dimethyl-1, 2-benzanthracene (DMBA) for 14 weeks and were excised at 10, 14, 19 weeks, respectively. The biopsies were classified pathologically (normal mucosa, hyperkeratosis, hyperplasia, dysplasia, early invasion, well and moderately differentiated carcinoma) and studied immunohistochemically. The two-tailed Student's t test was performed for each animal group and for each histological category.
RESULTS: The ets-1 expression increased in early stages of oral tumor formation and invasion. The expression of N-ras gradually decreased during oral oncogenesis, as previously observed with H-ras.
CONCLUSIONS: Neither N-ras nor H-ras affects ets-1 expression in contrast to other types of cancer in which N-ras and ets-1 are implicated in the same signalling pathway. Therefore, the existing pathway implicating these proteins might be somehow altered in oral cancer. It seems that ets-1 is a good prognostic marker for invasiveness and progression of oral cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17072648     DOI: 10.1007/s00432-006-0161-1

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  42 in total

1.  Immunohistochemical Expression of N-ras Oncogene is a Late Event in Head and Neck Carcinomas.

Authors:  John S McDonald; Keith M Wilson; Peter Gartside; Robert L Sonke; Ljiljana Pavelic; Eric Okum; Julie Neanen; Jack L Gluckman; Zlatko P Pavelic
Journal:  Pathol Oncol Res       Date:  1996       Impact factor: 3.201

Review 2.  Ras proteins in the control of the cell cycle and cell differentiation.

Authors:  P Crespo; J León
Journal:  Cell Mol Life Sci       Date:  2000-10       Impact factor: 9.261

Review 3.  Ets transcription factors: nuclear effectors of the Ras-MAP-kinase signaling pathway.

Authors:  B Wasylyk; J Hagman; A Gutierrez-Hartmann
Journal:  Trends Biochem Sci       Date:  1998-06       Impact factor: 13.807

Review 4.  N-ras and human cancer.

Authors:  I A McKay; H Paterson; R Brown; D Toksoz; C J Marshall; A Hall
Journal:  Anticancer Res       Date:  1986 May-Jun       Impact factor: 2.480

5.  ras gene mutations in oral cancer in eastern India.

Authors:  N Das; J Majumder; U B DasGupta
Journal:  Oral Oncol       Date:  2000-01       Impact factor: 5.337

6.  Ras/mitogen-activated protein kinase signaling activates Ets-1 and Ets-2 by CBP/p300 recruitment.

Authors:  Charles E Foulds; Mary L Nelson; Adam G Blaszczak; Barbara J Graves
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

7.  Ras gene point mutation is a rare event in premalignant tissues and malignant cells and tissues from oral mucosal lesions.

Authors:  W A Yeudall; L K Torrance; K A Elsegood; P Speight; C Scully; S S Prime
Journal:  Eur J Cancer B Oral Oncol       Date:  1993-01

8.  Coexpression of Ets-1 and p53 in oral carcinomas is associated with P-glycoprotein expression and poor prognosis.

Authors:  S Soni; P Pande; N K Shukla; R Ralhan
Journal:  J Cancer Res Clin Oncol       Date:  2002-04-24       Impact factor: 4.553

9.  The p53 tumor-suppressor gene and ras oncogene mutations in oral squamous-cell carcinoma.

Authors:  E Sakai; K Rikimaru; M Ueda; Y Matsumoto; N Ishii; S Enomoto; H Yamamoto; N Tsuchida
Journal:  Int J Cancer       Date:  1992-12-02       Impact factor: 7.396

10.  Low incidence of ras oncogene activation in human squamous cell carcinomas.

Authors:  G Rumsby; R L Carter; B A Gusterson
Journal:  Br J Cancer       Date:  1990-03       Impact factor: 7.640

View more
  4 in total

1.  Ets1 blocks terminal differentiation of keratinocytes and induces expression of matrix metalloproteases and innate immune mediators.

Authors:  Priyadharsini Nagarajan; Shu Shien Chin; Dan Wang; Song Liu; Satrajit Sinha; Lee Ann Garrett-Sinha
Journal:  J Cell Sci       Date:  2010-10-15       Impact factor: 5.285

2.  Immunohistochemical assessment of growth factor signaling molecules: MAPK, Akt, and STAT3 pathways in oral epithelial precursor lesions and squamous cell carcinoma.

Authors:  Kazuki Tashiro; Mariko Oikawa; Yasuhiro Miki; Tetsu Takahashi; Hiroyuki Kumamoto
Journal:  Odontology       Date:  2019-05-06       Impact factor: 2.634

3.  Inhibitory Effects of Glucosylceramide on Tumorigenesis Induced by a Carcinogen in Mice.

Authors:  Kazunori Fujiwara; Hiroaki Yazama; Ryouhei Donishi; Satoshi Koyama; Takahiro Fukuhara; Hiromi Takeuchi
Journal:  Laryngoscope       Date:  2019-12-06       Impact factor: 3.325

4.  Ets1 induces dysplastic changes when expressed in terminally-differentiating squamous epidermal cells.

Authors:  Priyadharsini Nagarajan; Neha Parikh; Lee Ann Garrett-Sinha; Satrajit Sinha
Journal:  PLoS One       Date:  2009-01-14       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.